Metformin Reduces Potassium Currents and Prolongs Repolarization in Non-Diabetic Heart

Metformin is the first choice drug for the treatment of type 2 diabetes due to positive results in reducing hyperglycaemia and insulin resistance. However, diabetic patients have higher risk of ventricular arrhythmia and sudden cardiac death, and metformin failed to reduce ventricular arrhythmia in...

Descripción completa

Detalles Bibliográficos
Autores principales: Malagueta-Vieira, Layse, Fernández-Ruocco, Julieta, Hortigón-Vinagre, María P., Zamora, Víctor, Zayas-Arrabal, Julián, Echeazarra, Leyre, Smith, Godfrey L., Vila Petroff, Martín, Medei, Emiliano, Casis, Óscar, Gallego, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181026/
https://www.ncbi.nlm.nih.gov/pubmed/35682699
http://dx.doi.org/10.3390/ijms23116021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181026/
https://www.ncbi.nlm.nih.gov/pubmed/35682699
http://dx.doi.org/10.3390/ijms23116021

Ejemplares similares